Riskpilot← Back to searchSign inGet full accessMMT Pharma Holding Oy
OYActiveY-tunnus 1962421-9Messukatu 15Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20052 employees
Revenue 2025
EUR 0
EBITDA margin
—
-13% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
EUR 49K
-96% vs 2024
| Revenue | EUR 0 | — |
| EBITDA | EUR -50K | -13% |
| Net profit | EUR 49K | -96% |
| Total assets | EUR 22,4M | -11% |
| Equity | EUR 22,4M | -8% |
| Employees | 2 | — |
Legal name
MMT Pharma Holding Oy
Y-tunnus number
1962421-9
Legal form
Osakeyhtiö
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
28. huhtikuuta 2005
Share capital
EUR 8 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on osakkeiden ja muiden arvopaperien sekä kiinteistöjen omistaminen, hallinnointi, vuokraus ja kauppa sekä muu laillinen liiketoiminta. Yhtiö voi lisäksi toimia oman tai vieraan pääoman ehtoisin instrumentein sijoitus-, kehitys- ja rahoitusyhtiönä. Lisäksi yhtiön toimialana on käydä arvopaperi- ja kiinteistökauppaa sekä omistaa, hallita ja vuokrata kiinteistöjä tai sellaisen hallintaan oikeuttavia osakkeita tai osakkuuksia sekä muita arvopapereita koti- ja ulkomailla.
Address
Messukatu 15
Phone
+3580503562909
Email
mika.nyyssonen@mmtpharma.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −20 | −10 | −10 | −24 | −18 |
| EBITDA | 864 | 868 | −45 | −44 | −50 |
| Depreciation & amort. | — | −2 | −2 | −1 | −1 |
| EBIT | 864 | 866 | −47 | −45 | −51 |
| Net financials | 981 | 183 | −174 | 1 644 | 234 |
| Profit before tax | 1 845 | 1 048 | 1 048 | 1 598 | 183 |
| Tax | 170 | 60 | 60 | 242 | 134 |
| Net profit | 1 675 | 988 | 988 | 1 357 | 49 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 28 756 | 27 606 | 2 527 905 | 25 110 | 22 393 |
| Equity | 28 617 | 27 606 | 25 278 | 24 307 | 22 356 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 139 | 1 | 1 | 803 | 37 |
| Total debt | 139 | 1 | 1 | 803 | 37 |
EBITDA margin
-5002300.0%
This company
15.8%
Market median
-31660227% vs market
20212025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
20212025
Net profit margin
4944200.0%
This company
8.1%
Market median
+61039406% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-09-30
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
SM | Audit | 2019 |
AJ Audit | Audit | 2013 |
MO Chief Executive Officer | Chief Executive Officer | 2005 |
LJ Deputy auditor | Deputy auditor | 2019 |
MK Deputy auditor | Deputy auditor | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2005 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MMT Pharma Holding Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanna Mari Hannele Saari | Audit | 0 companies |
| Arto Juhani Saarinen | Audit | 0 companies |
| Mika Olavi Nyyssönen | Chief Executive Officer | 0 companies |
| Lauri Jaakoppi Lähteenmaa | Deputy auditor | 0 companies |
| Matti Kalevi Oksanen | Deputy auditor | 0 companies |
| Jarmo Juhani Haukka | Board of Directors | 0 companies |